News
-
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
October 22, 2026 -
Third Quarter 2026 Letter to Shareholders
October 20, 2026 -
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
October 20, 2026 -
Aclarion to Present at the 20th Annual LD Micro Main Event
October 13, 2026 -
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
October 8, 2026 -
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
September 29, 2026 -
Aclarion Announces Addition of University of Arizona College of Medicine - Phoenix as CLARITY Trial Site
August 20, 2026 -
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
August 12, 2026 -
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine, First Site in Indiana to Offer the Technology
August 4, 2026 -
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
July 29, 2026